Sally C. Pipes
Commentary
Bernie’s Not-So-Subtle Single-Payer Plot
Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Sally C. Pipes
October 5, 2021
Commentary
Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up
For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
Sally C. Pipes
September 30, 2021
Commentary
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Sally C. Pipes
September 30, 2021
Commentary
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
Sally C. Pipes
September 27, 2021
Commentary
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Sally C. Pipes
September 27, 2021
Commentary
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Sally C. Pipes
September 19, 2021
Commentary
Biden’s Prescription Drug Plan Is Nothing More Than Price Controls
The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Sally C. Pipes
September 16, 2021
Commentary
Another Warning About Medicare Is Going Unheeded
The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
Sally C. Pipes
September 13, 2021
Medicaid
Democrats’ Latest Attempt To Expand Medicare Would Hurt Seniors
As part of their $3.5 trillion budget plan, Democrats hope to expand Medicare to include, among other additions, coverage for dental benefits by 2028. It’s a dream progressives have been pursuing for years. Sen. Bernie Sanders, I-Vt., called for the changes in his 2016 and 2020 presidential campaign platforms. House Speaker Nancy ...
Sally C. Pipes
September 13, 2021
Commentary
Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented
The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need ...
Sally C. Pipes
September 2, 2021
Bernie’s Not-So-Subtle Single-Payer Plot
Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up
For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Biden’s Prescription Drug Plan Is Nothing More Than Price Controls
The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Another Warning About Medicare Is Going Unheeded
The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
Democrats’ Latest Attempt To Expand Medicare Would Hurt Seniors
As part of their $3.5 trillion budget plan, Democrats hope to expand Medicare to include, among other additions, coverage for dental benefits by 2028. It’s a dream progressives have been pursuing for years. Sen. Bernie Sanders, I-Vt., called for the changes in his 2016 and 2020 presidential campaign platforms. House Speaker Nancy ...
Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented
The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need ...